-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下： DaVita公佈了2026年第一季強勁的業績，調整後每股收益為2.87美元，年增43.5%，遠高於此前2.33美元的普遍預期，這主要得益於更高的報銷率和持續積極的股票回購。儘管治療量面臨挑戰，但營收仍成長6.0%至34.16億美元，其中美國透析單次治療收入成長17.45美元至417.59美元，反映了更高的報銷率。儘管非收購治療量成長僅0.1%，但DaVita的穩健表現展現了其營運韌性。管理層將調整後每股收益預期從先前的13.60美元至15.00美元上調至14.10美元至15.20美元。儘管受季節性因素影響，營業利潤率較上季下降140個基點，仍提升50個基點至14.1%；自由現金流則從去年同期的-4,500萬美元大幅成長至1.4億美元。公司維持10億至12.5億美元的自由現金流預期，我們認為這將支持公司繼續向股東返還資本。
Related Articles
Asia
Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6%
Anteris Technologies (ASX:AVR) has enrolled and successfully treated the first US patients in its PARADIGM global pivotal trial of the DurAVR transcatheter heart valve for severe calcific aortic stenosis, according to a Wednesday Australian bourse filing.The procedures were carried out at Montefiore Medical Center in New York, the filing added.The company's shares rose 6% in recent Wednesday trade.
$ASX:AVR
Research
Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.
$BLDP
Research
Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from $3.00 to $4.70, applying a price-to-sales multiple of 13x our 2026 sales-per-share view of $0.36. We adjust our 2026 loss per share (LPS) estimate to -$0.19 from -$0.23 and our 2027 LPS view to -$0.11 from -$0.15. BLDP reported Q1 2026 revenue of $19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to $5.1M) and stationary power (up 775% to $5.2M), though Bus revenue declined 46% to $6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to $52.8M, while the total backlog fell 5% to $112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.
$BLDP